Patients with ≥ 20 × 10(9)/L Platelets at Baseline May Have a Prompt Response to Romiplostim During the Early Phase of Treatment: an Italian Single-Institution Experience

Patients with chronic immune thrombocytopenia treated with romiplostim may benefit from a higher starting dose when a rapid increase in count is needed, but it could be avoided in those with a prompt response to the standard dosage. We hypothesized that a platelet count ≥ 20 × 10(9)/l at baseline co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Baldini, Simone, Rigacci, Luigi, Carrai, Valentina, Alterini, Renato, Fjerza, Rajmonda, Bosi, Alberto
Formato: Artigo
Idioma:Inglês
Publicado em: Università Cattolica del Sacro Cuore 2012
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395680/
https://ncbi.nlm.nih.gov/pubmed/22811793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2012.044
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados